Literature DB >> 17509751

The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease.

Miet De Letter1, Patrick Santens, Marc De Bodt, Georges Van Maele, John Van Borsel, Paul Boon.   

Abstract

OBJECTIVES: Hypokinetic dysarthria is commonly encountered in Parkinson's disease (PD). Although the etiology of this dysarthria is multifactorial, disorders of respiration may strongly contribute to it. The aim of this study was to evaluate the effects of levodopa on measures of respiration and intelligibility. PATIENTS AND METHODS: Vital capacity (VC), sustained vowel phonation (SVP) and phonation quotient (PQ) were determined with and without medication in 25 patients suffering from idiopathic PD. Intelligibility was evaluated by three independent speech pathologists using the word subtest protocol of the Yorkston and Beukelman "Assessment of intelligibility of dysarthric speech" (AIDS).
RESULTS: VC was abnormal in 18/25 patients in the off-condition and 15/25 in the on-condition. SVP was normal in 22/25 patients in the off-state and in all patients in the on-state. PQ was normal in all patients in the off- and on-condition. All three respiratory parameters, as well as intelligibility, improved significantly following administration of levodopa. There were significant differences between men and women for VC and PQ, with men having the highest values for both parameters in both conditions. In none of the two conditions a correlation between respiratory parameters and intelligibility could be demonstrated.
CONCLUSION: This study suggests that thoracic mobility is decreased in PD, and that pharmacological treatment results in improvement, but not in normalization. Moreover, it remains unclear to what extent dyskinesias negatively influence respiratory control. Our results also demonstrate improvement of intelligibility after pharmacological treatment of PD. However, this improvement is not solely the consequence of respiratory changes. Further research on the effects of different characteristics on intelligibility is necessary.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509751     DOI: 10.1016/j.clineuro.2007.04.003

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  17 in total

1.  Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy.

Authors:  Jan Rusz; Roman Cmejla; Hana Růžičková; Jiří Klempíř; Veronika Majerová; Jana Picmausová; Jan Roth; Evžen Růžička
Journal:  J Neural Transm (Vienna)       Date:  2012-07-08       Impact factor: 3.575

2.  Voice and fluency changes as a function of speech task and deep brain stimulation.

Authors:  Diana Van Lancker Sidtis; Tiffany Rogers; Violette Godier; Michele Tagliati; John J Sidtis
Journal:  J Speech Lang Hear Res       Date:  2010-07-19       Impact factor: 2.297

3.  Neural correlates of efficacy of voice therapy in Parkinson's disease identified by performance-correlation analysis.

Authors:  Shalini Narayana; Peter T Fox; Wei Zhang; Crystal Franklin; Donald A Robin; Deanie Vogel; Lorraine O Ramig
Journal:  Hum Brain Mapp       Date:  2010-02       Impact factor: 5.038

4.  The effects of a simulated fMRI environment on voice intensity in individuals with Parkinson's disease hypophonia and older healthy adults.

Authors:  Jordan L Manes; Ellen Herschel; Katharine Aveni; Kris Tjaden; Todd Parrish; Tanya Simuni; Daniel M Corcos; Angela C Roberts
Journal:  J Commun Disord       Date:  2021-08-31       Impact factor: 2.288

5.  Short- and long-term dopaminergic effects on dysarthria in early Parkinson's disease.

Authors:  Sabine Skodda; Wenke Visser; Uwe Schlegel
Journal:  J Neural Transm (Vienna)       Date:  2009-12-12       Impact factor: 3.575

6.  Deep brain stimulation exacerbates hypokinetic dysarthria in a rat model of Parkinson's disease.

Authors:  Nathaniel O King; Collin J Anderson; Alan D Dorval
Journal:  J Neurosci Res       Date:  2015-10-26       Impact factor: 4.164

7.  Research-based Updates in Swallowing and Communication Dysfunction in Parkinson Disease: Implications for Evaluation and Management.

Authors:  C K Broadfoot; D Abur; J D Hoffmeister; C E Stepp; M R Ciucci
Journal:  Perspect ASHA Spec Interest Groups       Date:  2019-10-11

8.  Levodopa effects on hand and speech movements in patients with Parkinson's disease: a FMRI study.

Authors:  Audrey Maillet; Alexandre Krainik; Bettina Debû; Irène Troprès; Christelle Lagrange; Stéphane Thobois; Pierre Pollak; Serge Pinto
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

9.  A preliminary report on disordered speech with deep brain stimulation in individuals with Parkinson's disease.

Authors:  Christopher Dromey; Suzy Bjarnason
Journal:  Parkinsons Dis       Date:  2011-10-16

10.  Effect of deep brain stimulation on speech performance in Parkinson's disease.

Authors:  Sabine Skodda
Journal:  Parkinsons Dis       Date:  2012-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.